Your browser doesn't support javascript.
loading
Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.
McLaughlin, P; Grillo-López, A J; Link, B K; Levy, R; Czuczman, M S; Williams, M E; Heyman, M R; Bence-Bruckler, I; White, C A; Cabanillas, F; Jain, V; Ho, A D; Lister, J; Wey, K; Shen, D; Dallaire, B K.
Afiliación
  • McLaughlin P; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Grillo-López AJ; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Link BK; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Levy R; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Czuczman MS; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Williams ME; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Heyman MR; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Bence-Bruckler I; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • White CA; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Cabanillas F; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Jain V; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Ho AD; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Lister J; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Wey K; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Shen D; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
  • Dallaire BK; Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. pmclaugh@notes.mdacc.tmc.edu.
J Clin Oncol ; 41(2): 154-162, 2023 01 10.
Article en En | MEDLINE | ID: mdl-36603541
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos